000 | 01862pam a2200349 i 4500 | ||
---|---|---|---|
999 |
_c59118 _d59118 |
||
001 | 1709391 | ||
005 | 20180717122643.0 | ||
008 | 170713s2018 paua b 001 0 eng | ||
010 | _a 2017033412 | ||
020 | _a9781496347282 | ||
020 | _a9781496372918 | ||
020 | _a1496347285 | ||
040 |
_aDNLM _beng _erda _cDNLM |
||
041 | 0 | 9 | _aeng |
042 | _apcc | ||
060 | 0 | 0 | _a2018 B-127 |
060 | 1 | 0 | _aQV 786 |
082 | 0 | 4 |
_a615.19 _bA A |
100 | 1 |
_aAllen, Loyd V. _cJr., _eauthor. _93864 |
|
245 | 1 | 0 |
_aAnsel's pharmaceutical dosage forms and drug delivery systems / _cLoyd V. Allen, Jr. |
246 | 1 | _aPharmaceutical dosage forms and drug delivery systems | |
250 | _aEleventh edition. | ||
260 |
_aPhiladelphia ; _bWolters Kluwer. _c2018. |
||
265 | _aالمكتبة الأكاديمية | ||
300 |
_ax, 630 pages : _billustrations ; _c30 cm. |
||
504 | _aIncludes bibliographical references and index. | ||
505 | 0 | _aIntroduction to drugs and pharmacy -- New drug development and approval process -- Current good manufacturing practices and current good compounding practices -- Dosage form design: pharmaceutical and formulation considerations -- Dosage form design: biopharmaceutical and pharmacokinetic considerations -- Powders and granules -- Capsules -- Tablets -- Solid oral modified-release dosage forms and drug delivery systems -- Ointments, creams, and gels -- Transdermals and transdermal drug delivery systems -- Suppositories, inserts, and sticks -- Solutions -- Disperse systems -- Parenterals -- Biologics -- Special solutions and suspensions -- Radiopharmaceuticals -- Products of biotechnology -- Novel dosage forms and drug delivery technologies -- Clinical pharmaceutics. | |
650 | 1 | 4 |
_aDosage Forms _93867 |
650 | 1 | 4 |
_aDrug Delivery Systems _93868 |
942 |
_2ddc _cBK _iFOP _6FOP |
||
995 |
_aAUTH _b20170713 _cREV _d20180221 |